Melqart Asset Management (Uk) LTD Roivant Sciences Ltd. Transaction History
Melqart Asset Management (Uk) LTD
- $1.03 Billion
- Q3 2024
A detailed history of Melqart Asset Management (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Melqart Asset Management (Uk) LTD holds 742,070 shares of ROIV stock, worth $8.44 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
742,070
Previous 1,265,609
41.37%
Holding current value
$8.44 Million
Previous $13.4 Million
35.99%
% of portfolio
0.84%
Previous 1.13%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$750 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$748 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$615 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$474 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$402 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.01B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...